Skip to main content

Table 1 Affinities (IC50 values) of the PSMA inhibitors in this study as determined in a competitive binding assay on LNCaP cells (150,000 cells/well, 4 °C, 1 h, c(125I-IBA) = 0.2 nM as the reference ligand). Data are expressed as mean ± SD (n = 3). *Data were taken from Ref. [17]

From: Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity

PSMA inhibitor

PSMA inhibitors (amino acid code)

IC50

1

Ac-YFK(Sub-KuE)

15.0 ± 1.3

2

Ac-YWK(Sub-KuE)

6.8 ± 3.3

3

Ac-Y-(Benzothienyl-A)K(Sub-KuE)

10.2 ± 4.0

4

Ac-Y-(Biphenyl-A)K(Sub-KuE)

139.4 ± 117.0

5

Ac-Y-1-Nal-K(Sub-KuE)

4.3 ± 0.9

6

Ac-Y-2-Nal-K(Sub-KuE)

3.9 ± 1.7

7

Ac-Y(4-NO2-F)K(Sub-KuE)

7.4 ± 0.5

8

Ac-Y(3,5-di-I-Y)K(Sub-KuE)

3.8 ± 0.6

9

Ac-Y(3-CH3-Y)K(Sub-KuE)

7.2 ± 0.9

PSMA I&T

DOTAGA-(I-y)fk(Sub-KuE)

10.2 ± 3.5*

natGa-PSMA I&T

natGa-DOTAGA-(I-y)fk(Sub-KuE)

9.3 ± 3.3*

natLu-PSMA I&T

natLu-DOTAGA-(I-y)fk(Sub-KuE)

7.9 ± 2.4*

10

DOTAGA-y-2-nal-k(Sub-KuE)

8.5 ± 2.5

natGa-10

natGa-DOTAGA-y-2-nal-k(Sub-KuE)

9.8 ± 3.2

natLu-10

natLu-DOTAGA-y-2-nal-k(Sub-KuE)

2.1 ± 0.8

11

DOTAGA-y-2-nal-k((I-f)-Glut-KuE)

4.6 ± 0.9

natGa-11

natGa-DOTAGA-y-2-nal-k((I-f)-Glut-KuE)

9.3 ± 2.9

natLu-11

natLu-DOTAGA-y-2-nal-k((I-f)-Glut-KuE)

6.1 ± 1.6